Clinical Trial Update: Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure [Phase 2]

View source ↗

Summary

Phase 2 evaluation of the ELAD System for acute liver failure has been completed. The update notes sponsor Vital Therapies, Inc. and the current trial status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Fulminant Hepatic Failure
• Liver Failure

Drugs mentioned

• ELAD System

Snippet

Sponsor: Vital Therapies, Inc. | Conditions: Fulminant Hepatic Failure | Phase 2 | Status: COMPLETED